DK164054C - N-benzoyl-n'-oe4-(2-pyrimidinyloxy)phenylaa-urinstofforbindelser, fremgangsmaade til fremstilling af samme samt antitumorpraeparater indeholdende disse - Google Patents

N-benzoyl-n'-oe4-(2-pyrimidinyloxy)phenylaa-urinstofforbindelser, fremgangsmaade til fremstilling af samme samt antitumorpraeparater indeholdende disse

Info

Publication number
DK164054C
DK164054C DK596586A DK596586A DK164054C DK 164054 C DK164054 C DK 164054C DK 596586 A DK596586 A DK 596586A DK 596586 A DK596586 A DK 596586A DK 164054 C DK164054 C DK 164054C
Authority
DK
Denmark
Prior art keywords
phenylaa
pyrimidinyloxy
benzoyl
procedure
preparations containing
Prior art date
Application number
DK596586A
Other languages
English (en)
Other versions
DK596586A (da
DK596586D0 (da
DK164054B (da
Inventor
Takahiro Haga
Nobutoshi Yamada
Hideo Sugi
Toru Koyanagi
Hiroshi Okada
Original Assignee
Ishihara Sangyo Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ishihara Sangyo Kaisha filed Critical Ishihara Sangyo Kaisha
Publication of DK596586D0 publication Critical patent/DK596586D0/da
Publication of DK596586A publication Critical patent/DK596586A/da
Publication of DK164054B publication Critical patent/DK164054B/da
Application granted granted Critical
Publication of DK164054C publication Critical patent/DK164054C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • C07D213/6432-Phenoxypyridines; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK596586A 1985-12-11 1986-12-11 N-benzoyl-n'-oe4-(2-pyrimidinyloxy)phenylaa-urinstofforbindelser, fremgangsmaade til fremstilling af samme samt antitumorpraeparater indeholdende disse DK164054C (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP27818085 1985-12-11
JP27818085 1985-12-11
JP27988485 1985-12-12
JP27988485 1985-12-12
JP28069485 1985-12-13
JP60280694 1985-12-13

Publications (4)

Publication Number Publication Date
DK596586D0 DK596586D0 (da) 1986-12-11
DK596586A DK596586A (da) 1987-06-12
DK164054B DK164054B (da) 1992-05-04
DK164054C true DK164054C (da) 1992-09-28

Family

ID=27336532

Family Applications (2)

Application Number Title Priority Date Filing Date
DK596586A DK164054C (da) 1985-12-11 1986-12-11 N-benzoyl-n'-oe4-(2-pyrimidinyloxy)phenylaa-urinstofforbindelser, fremgangsmaade til fremstilling af samme samt antitumorpraeparater indeholdende disse
DK911183A DK118391D0 (da) 1985-12-11 1991-06-18 N-benzoylurinstofforbindelser, fremgangsmaade til fremstilling af samme samt antitumorsammensaetning indeholdende disse

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK911183A DK118391D0 (da) 1985-12-11 1991-06-18 N-benzoylurinstofforbindelser, fremgangsmaade til fremstilling af samme samt antitumorsammensaetning indeholdende disse

Country Status (14)

Country Link
US (1) US4863924A (da)
EP (1) EP0226104B1 (da)
JP (1) JPH0745473B2 (da)
KR (1) KR870006016A (da)
AR (1) AR244667A1 (da)
AT (1) ATE60760T1 (da)
AU (1) AU594098B2 (da)
DE (1) DE3677478D1 (da)
DK (2) DK164054C (da)
ES (1) ES2033675T3 (da)
GR (1) GR3001905T3 (da)
IL (1) IL80776A (da)
NZ (1) NZ218440A (da)
PL (1) PL151012B1 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ212208A (en) * 1984-06-15 1988-04-29 Ishihara Sangyo Kaisha N-benzoyl-n'-pyrimidinyloxyphenyl ureas and pharmaceutical compositions
JPS62185013A (ja) * 1986-02-08 1987-08-13 Green Cross Corp:The 易吸収性医薬組成物
US5166180A (en) * 1988-01-11 1992-11-24 Duphar International Research B.V. Method of treating hematologic diseases and pharmaceutical composition to be used therefor
DK5489A (da) * 1988-01-11 1989-07-12 Duphar Int Res Anvendelse af substituerede amidforbindelser til fremstilling af farmaceutiske praeparater til behandling af haematologiske sygdomme
JPH029855A (ja) * 1988-03-31 1990-01-12 Ishihara Sangyo Kaisha Ltd 置換ベンゼン誘導体、それらの製造方法及びそれらを含有する抗癌性組成物
US5202487A (en) * 1988-09-13 1993-04-13 L'oreal 2-substituted para-aminophenols and their use for dyeing keratinous fibres
FR2637282B1 (fr) * 1988-09-13 1990-12-07 Oreal Para-aminophenols 2-substitues et leur utilisation pour la teinture des fibres keratiniques
JPH02196719A (ja) * 1989-01-24 1990-08-03 Green Cross Corp:The 粉末状医薬組成物
NZ234551A (en) * 1989-07-28 1991-10-25 Ishihara Sangyo Kaisha Benzoylurea derivatives and antitumour compositions
US6344476B1 (en) * 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US7329670B1 (en) * 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
CA2359244C (en) 1999-01-13 2013-10-08 Bayer Corporation .omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP1140840B1 (en) 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
ME00275B (me) 1999-01-13 2011-02-10 Bayer Corp ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
EP1437344A4 (en) * 2001-09-28 2006-09-20 Takeda Pharmaceutical BENZOL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
ES2275931T5 (es) * 2001-12-03 2018-10-23 Bayer Healthcare Llc Compuestos de aril-urea en combinación con otros agentes citostáticos o citotóxicos para tratamiento de cánceres humanos
US20040023961A1 (en) * 2002-02-11 2004-02-05 Bayer Corporation Aryl ureas with raf kinase and angiogenisis inhibiting activity
WO2003068229A1 (en) * 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
DK1478358T3 (da) 2002-02-11 2013-10-07 Bayer Healthcare Llc Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese
WO2003068746A1 (en) 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Aryl ureas as kinase inhibitors
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
PT1626714E (pt) 2003-05-20 2007-08-24 Bayer Pharmaceuticals Corp Diarilureias para doenças mediadas por pdgfr
ES2297490T3 (es) 2003-07-23 2008-05-01 Bayer Pharmaceuticals Corporation Omega-carboxiarildifenilurea fluoro sustituida para el tratamiento y prevencion de enfermadades y afecciones.
EP1689376A2 (en) * 2003-11-28 2006-08-16 Novartis AG Diaryl urea derivatives in the treatment of protein kinase dependent diseases
JP5304241B2 (ja) 2005-03-07 2013-10-02 バイエル・ヘルスケア・エルエルシー 癌の処置用のオメガ−カルボキシアリール置換ジフェニルウレアを含む医薬組成物
KR102381581B1 (ko) 2014-01-16 2022-04-04 에프엠씨 코포레이션 제초제로서의 피리미디닐옥시 벤젠 유도체
CA2969816C (en) 2015-03-18 2022-03-01 E I Du Pont De Nemours And Company Substituted pyrimidinyloxy pyridine derivatives as herbicides
TWI713530B (zh) * 2015-06-05 2020-12-21 美商艾佛艾姆希公司 作為除草劑之嘧啶氧基苯衍生物
AU2016292811B2 (en) 2015-07-13 2021-02-18 Fmc Corporation Aryloxypyrimidinyl ethers as herbicides
WO2018204164A1 (en) 2017-05-02 2018-11-08 Fmc Corporation Pyrimidinyloxy benzo-fused compounds as herbicides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5615272A (en) * 1979-07-17 1981-02-14 Ishihara Sangyo Kaisha Ltd N-benzoyl-n'-phenylurea compound, its preparation, and insecticide containing the same
CA1233822A (en) * 1982-12-30 1988-03-08 David T. Chou Pesticidal benzoyl ureas and process for preparation
NZ212208A (en) * 1984-06-15 1988-04-29 Ishihara Sangyo Kaisha N-benzoyl-n'-pyrimidinyloxyphenyl ureas and pharmaceutical compositions
JPS6133176A (ja) * 1984-07-24 1986-02-17 Ishihara Sangyo Kaisha Ltd N−ニトロベンゾイル−n’−ピリダジニルオキシフエニルウレア系化合物、それらの製造方法及びそれらを含有する抗癌剤
JPS6193163A (ja) * 1984-10-12 1986-05-12 Ishihara Sangyo Kaisha Ltd N−ベンゾイル−n′−フエニルウレア系化合物、それらの製造方法並びにそれらを含有する抗癌剤
US4727077A (en) * 1985-02-20 1988-02-23 Ishihara Sangyo Kaisha Ltd. Benzoyl urea compounds, process for their production, and antitumorous compositions containing them

Also Published As

Publication number Publication date
AU594098B2 (en) 1990-03-01
GR3001905T3 (en) 1992-11-23
PL262901A1 (en) 1988-09-29
EP0226104A2 (en) 1987-06-24
EP0226104A3 (en) 1988-09-07
KR870006016A (ko) 1987-07-08
AU6558186A (en) 1987-06-18
NZ218440A (en) 1989-06-28
DE3677478D1 (de) 1991-03-14
DK596586A (da) 1987-06-12
PL151012B1 (en) 1990-07-31
ATE60760T1 (de) 1991-02-15
AR244667A1 (es) 1993-11-30
JPH0745473B2 (ja) 1995-05-17
DK118391A (da) 1991-06-18
JPS6399056A (ja) 1988-04-30
US4863924A (en) 1989-09-05
IL80776A (en) 1991-03-10
IL80776A0 (en) 1987-02-27
DK596586D0 (da) 1986-12-11
DK118391D0 (da) 1991-06-18
DK164054B (da) 1992-05-04
EP0226104B1 (en) 1991-02-06
ES2033675T3 (es) 1993-04-01

Similar Documents

Publication Publication Date Title
DK164054C (da) N-benzoyl-n'-oe4-(2-pyrimidinyloxy)phenylaa-urinstofforbindelser, fremgangsmaade til fremstilling af samme samt antitumorpraeparater indeholdende disse
DK163991C (da) Dichloranilinderivater, fremgangsmaade til fremstilling af disse, samt farmaceutiske praeparater indeholdende derivaterne
DK80291A (da) 1,3,9,9a-tetrahydro-imidazooe4,5-baaquinolin-2-oner samt fremgangsmaade til fremstilling deraf
EP0193334A3 (en) Optical cards and processes for preparing the same
DK356885A (da) 3-aminomethyl-imidazo(1,2-a)pyridinderivater samt fremgangsmaade til fremstilling af og laegemiddel indeholdende saadanne forbindelser
DK409784A (da) Substituerede phenyl-alifatiske isoxaler, fremgangsmaade til fremstilling deraf samt antivirale praeparater indeholdende disse
DK83386D0 (da) Disaccharid- og trisaccharid-derivater af aelipid aae-typen, praeparaterder indeholder disse samt fremgangsmaade til fremstilling af disse
DK206785A (da) Benzazepinderivater, laegemidler indeholdende disse samt fremgangsmaade til fremstilling deraf
DK511486A (da) 1,2,4-triazol-3-carboxamidforbindelser, fremgangsmaade til fremstilling heraf samt herbicide midler indeholdende samme
EG17981A (en) Herbicide for paddy fields
DK165979C (da) 1-dimethylcarbamoyl-3-substitueret-5-substitueret-1h-1,2,4-triazoler, praeparater indeholdende disse forbindelser, anvendelse af forbindelserne og praeparaterne og en fremgangsmaade til fremstilling af forbindelserne
DK160558C (da) N6-substituerede adenosiner, fremstilling og anvendelse af disse, samt farmaceutiske praeparater indeholdende saadanne forbindelser
DK457985D0 (da) 5-fluor-2 -deoxyuridinderivater og salte heraf, fremgangsmaade til fremstilling af disse samt antitumorpraeparater indeholdende disse praeparater
DK553689D0 (da) Phenyloxypropanolaminderivater, fremgangsmaade til fremstilling af saadanne forbindelser samt laegemiddel indeholdende disse
PL261454A1 (en) Herbicide containing novel 2-aryl-4,5,6,7-tetrahydroisoindolinones
DK162890C (da) N-benzoyl-n'-pyrimidinyloxyphenylurinstofforbindelser, fremgangsmaade til fremstilling af disse, samt antitumorpraeparater indeholdende forbindelserne
DK93385D0 (da) 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazoliner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser
DK160885D0 (da) Benzazepinderivater, fremgangsmaade til fremstilling deraf samt praeparater indeholdende disse
DK465487D0 (da) Anxiolytiske praeparater indeholdende dioxopiperidinderivater
DK239385A (da) Krystallinske metallophosphoaluminater samt fremgangsmaade til fremstilling og anvendelse af disse
DK51785D0 (da) 1,4-aminoalkylamino-9h-thioxanthen-9-oner, laegemidler indeholdende disse samt fremgangsmaade til fremstilling deraf
DK26591A (da) Cytidin-5'-diphosphatalkanoler og -glyceroler, fremgangsmaade til fremstilling heraf og praeparater indeholdende disse forbindelser
DK365087D0 (da) 1,3,5-trithianderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
DK573485D0 (da) Fremgangsmaade til fremstilling af optiske isomere af thiazolo-(3,2-a)pyrimidiner, de fremstillede isomere, farmaceutiske praeparater indeholdende disse og mellemprodukter til gennemfoerelse af fremgangsmaaden
DK163124C (da) N-benzoyl-n'-pyrimidinyloxyphenylurinstofforbindelser, fremgangsmaade til fremstilling heraf samt antitumorpraeparater indeholdende forbindelserne

Legal Events

Date Code Title Description
PBP Patent lapsed